20050603
 Novartis AG: Pact Is Reached to Develop Anadys's Hepatitis Drug   The Wall Street Journal,  Jun 3, 2005  Novartis AG signed an exclusive licensing agreement with Anadys Pharmaceuticals Inc. for a hepatitis drug and may pay Anadys as much as $570 million, the companies said.   
